Radiofarmacos para medicina nuclear
About This Opportunity
Supplies contract awarded by Chile Mercadopublico (Chile): Radiofarmacos para medicina. healthcare. Awarded to POSITRONPHARMA S A (CLP 206.4M, Mar 2026).
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender, originating from Chile and published on the chile_mercadopublico platform, seeks the supply of radiopharmaceuticals for nuclear medicine applications. The contracting authority is procuring these specialized medical materials to support diagnostic and therapeutic procedures within the national healthcare system. Radiopharmaceuticals are radioactive substances used in small quantities to diagnose and treat various diseases. They are injected, swallowed, or inhaled by patients, and their distribution within the body is monitored using imaging techniques or by measuring the radiation emitted.
Typical requirements for such tenders include a demonstrated ability to reliably supply a range of radiopharmaceutical products, adhering to strict quality control and regulatory standards mandated by Chilean health authorities. Suppliers will likely need to possess the necessary certifications and licenses for the production, handling, and distribution of radioactive materials. Furthermore, the tender will likely specify requirements for product efficacy, shelf-life, packaging, and cold chain logistics to ensure the integrity and timely delivery of these sensitive substances. Bidders may also be required to provide technical support and training related to the use and handling of the supplied radiopharmaceuticals. The objective is to secure a consistent and high-quality supply of these essential medical isotopes and radiolabeled compounds to advance diagnostic capabilities and treatment options in nuclear medicine across Chile.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 96 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to POSITRONPHARMA S A. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
POSITRONPHARMA S A was awarded the contract for CLP 206,354,184. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.